Oxidative stress in the thyroid gland: From harmlessness to hazard depending on the iodine content

Endocrinology

Volumn 149, Issue 1, 2008, Pages 424-433

  Poncin, Sylvie ^a   Gérard, Anne Catherine ^a   Boucquey, Marie ^a   Senou, Maximin ^a   Calderon, Pedro Buc ^a   Knoops, Bernard ^a   Lengelé, Benoît ^a   Many, Marie Christine ^a   Colin, Ides M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 4 HYDROXYNONENAL; BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; GLUTATHIONE PEROXIDASE; IODINE; PEROXIREDOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GOITER; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID GLAND; UPREGULATION;

ALGORITHMS; ANIMALS; ANTIOXIDANTS; CARCINOGENS; CYTOPROTECTION; DISEASE PROGRESSION; EPOXY COMPOUNDS; FEMALE; GLUTATHIONE PEROXIDASE; GOITER; IODINE; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PEROXIREDOXINS; PPAR GAMMA; PROSTAGLANDIN D2; RATS; RATS, WISTAR; REMISSION INDUCTION; THYROID GLAND; THYROIDITIS;

EID: 37549013371     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0951     Document Type: Article

References (53)

1. Denef JF, Many MC, van den Hove MF 1996 Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism? Mol Cell Endocrinol 121:101-103
2. Many MC, Mestdagh C, van den Hove MF, Denef JF 1992 In vitro study of acute toxic effects of high iodide doses in human thyroid follicles. Endocrinology 131:621-630
3. Belshaw BE, Becker DV 1973 Necrosis of follicular cells and discharge of thyroidal iodine induced by administering iodide to iodine-deficient dogs. J Clin Endocrinol Metab 36:466-474
4. Wollman SH, Breitman TR 1970 Changes in DNA and weight of thyroid glands during hyperplasia and involution. Endocrinology 86:322-327
5. Mahmoud I, Colin I, Many MC, Denef JF 1986 Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol 44:259-271
6. Many MC, Maniratunga S, Denef JF 1996 The non-obese diabetic (NOD) mouse: an animal model for autoimmune thyroiditis. Exp Clin Endocrinol Diabetes 104(Suppl 3):17-20
7. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF 1995 Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147:311-320
8. Many MC, Denef JF, Hamudi S, Cornette C, Haumont S, Beckers C 1986 Effects of iodide and thyroxine on iodine-deficient mouse thyroid: a morphological and functional study. J Endocrinol 110:203-210
9. Many MC, Denef JF, Gathy P, Haumont S 1983 Morphological and functional changes during thyroid hyperplasia and involution in C3H mice: evidence for folliculoneogenesis during involution. Endocrinology 112:1292-1302
10. Mutaku JF, Poma JF, Many MC, Denef JF, van den Hove MF 2002 Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. J Endocrinol 172:375-386
11. Toussaint-Demylle D, Many MC, Theisen H, Kraal G, Denef JF 1990 Effects of iodide on class II-MHC antigen expression in iodine deficient hyperplastic thyroid glands. Autoimmunity 7:51-62
12. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C 2006 Effect of iodine intake on thyroid diseases in China. N Engl J Med 354:2783-2793
13. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimuro K, Hayakawa N, Hayashi R, Nakai A, Ishizuki Y, Nagasaka A 1997 Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 29:351-354
14. Gerard AC, Many MC, Daumerie C, Knoops B, Colin IM 2005 Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 15:205-209
15. Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, Kwon OY, Kim YK, Ro HK, Shong M 2000 Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275:18266-18270
16. Kohrle J, Jakob F, Contempre B, Dumont JE 2005 Selenium, the thyroid, and the endocrine system. Endocr Rev 26:944-984
17. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 128:779-785
18. Straus DS, Glass CK 2001 Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185-210
19. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK 1998 The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82
20. Mutaku JF, Many MC, Colin I, Denef JF, van den Hove MF 1998 Antigoitrogenic effect of combined supplementation with DL-α- tocopherol, ascorbic acid and β-carotene and of DL-α- tocopherol alone in the rat. J Endocrinol 156:551-561
21. Colin IM, Selvais PL, Rebai T, Maiter DM, Adam E, vanDenhove MF, Ketelslegers JM, Denef JF 1994 Expression of the endothelin-1 gene in the rat thyroid gland and changes in its peptide and mRNA levels in goiter formation and iodide-induced involution. J Endocrinol 143:65-74
22. Colin IM, Nava E, Toussaint D, Maiter DM, vanDenhove MF, Luscher TF, Ketelslegers JM, Denef JF, Jameson JL 1995 Expression of nitric oxide synthase isoforms in the thyroid gland: evidence for a role of nitric oxide in vascular control during goiter formation. Endocrinology 136:5283-5290
23. 2 attenuates the development of acute and chronic inflammation. Mol Pharmacol 61:997-1007
24. Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, Sortino M, Crimi N, Caputi AP, Thiemermann C, Vancheri C 2005 Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J 25:225-234
25. Tsai L, Szweda PA, Vinogradova O, Szweda LI 1998 Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc Natl Acad Sci USA 95:7975-7980
26. Vince V, Thil MA, Gerard AC, Veraart C, Delbeke J, Colin IM 2005 Cuff electrode implantation around the sciatic nerve is associated with an upregulation of TNF-α and TGF-β1. J Neuroimmunol 159:75-86
27. Gerard AC, Boucquey M, van den Hove MF, Colin IM 2006 Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1α/IFN- γ, an effect partially mediated by nitric oxide. Am J Physiol Endocrinol Metab 291:E242-E253
28. Colin IM, Isaac J, Dupret P, Ledant T, D'Hautcourt JL 2004 Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 18:72-76
29. van den Hove MF, Stoenoiu MS, Croizet K, Couvreur M, Courtoy PJ, Devuyst O, Colin IM 2002 Nitric oxide is involved in interleukin-1α- induced cytotoxicity in polarised human thyrocytes. J Endocrinol 173:177-185
30. Bjorkman U, Ekholm R 1992 Hydrogen peroxide generation and its regulation in FRTL-5 and porcine thyroid cells. Endocrinology 130:393-399
31. 2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult. J Endocrinol 192:615-626
32. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79:152-159
33. Knoops B, Clippe A, Bogard C, Arsalane K, Wattiez R, Hermans C, Duconseille E, Falmagne P, Bernard A 1999 Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J Biol Chem 274:30451-30458
34. Dubuisson M, Vander SD, Clippe A, Etienne F, Nauser T, Kissner R, Koppenol WH, Rees JF, Knoops B 2004 Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett 571:161-165
35. Banmeyer I, Marchand C, Clippe A, Knoops B 2005 Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 579:2327-2333
36. Banmeyer I, Marchand C, Verhaeghe C, Vucic B, Rees JF, Knoops B 2004 Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med 36:65-77
37. 2 generation in thyroid slices from several species. Am J Physiol Endocrinol Metab 278:E692-E699
38. Wong CM, Siu KL, Jin DY 2004 Peroxiredoxin-null yeast cells are hypersensitive to oxidative stress and are genomically unstable. J Biol Chem 279:23207-23213
39. Huang ME, Kolodner RD 2005 A biological network in Saccharomyces cerevisiae prevents the deleterious effects of endogenous oxidative DNA damage. Mol Cell 17:709-720
40. Contempre B, Denef JF, Dumont JE, Many MC 1993 Selenium deficiency aggravates the necrotizing effects of a high iodide dose in iodine deficient rats. Endocrinology 132:1866-1868
41. Contempre B, Dumont JE, Denef JF, Many MC 1995 Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endocrinol 133:99-109
42. Contempre B, de Escobar GM, Denef JF, Dumont JE, Many MC 2004 Thiocyanate induces cell necrosis and fibrosis in selenium- and iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. Endocrinology 145:994-1002
43. Jiang C, Ting AT, Seed B 1998 PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86
44. Petrova TV, Akama KT, Van Eldik LJ 1999 Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Δ12,14-prostaglandin J2. Proc Natl Acad Sci USA 96: 4668-4673
45. Hortelano S, Castrillo A, Alvarez AM, Bosca L 2000 Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol 165:6525-6531
46. Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD 2000 Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 164:6503-6508
47. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD 1999 A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383-389
48. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354-366
49. 2 facilitates thyroglobulin production by cultured human thyrocytes. Am J Physiol Cell Physiol 279:C1859-C1869
50. Cuzzocrea S 2004 Peroxisome proliferator-activated receptors γ ligands and ischemia and reperfusion injury. Vascul Pharmacol 41:187-195
51. Kim EH, Surh YJ 2006 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 72:1516-1528
52. Vaidya S, Somers EP, Wright SD, Detmers PA, Bansal VS 1999 15-Deoxy-Δ12,1412,14-prostaglandin J2 inhibits the β2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation. J Immunol 163:6187-6192
53. Sandig H, Pease JE, Sabroe I 2007 Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J Leukoc Biol 81:372-382